Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 09 tags : Application save search
Outlook on the Biobutanol Global Market to 2026 - by Raw Material, Application, End-user Industry and Region
Published: 2021-12-09 (Crawled : 21:00) - prnewswire.com
EMN | $96.8 -0.27% 0.0% 520K
|
Process Industries
|
| O: 1.46%
H: 0.23%
C: -0.55%
application
STMicroelectronics Drives the Future of EVs and Industrial Applications with New Silicon-Carbide Devices
Published: 2021-12-09 (Crawled : 14:30) - globenewswire.com
STMEF | News | $39.602 -5.77% 1.9K
|
Electronic Technology
|
| O: -0.26%
H: 0.0%
C: -2.81%
STM | News | $39.98 1.86% 2.28% 3.2M
|
Electronic Technology
|
| O: -1.91%
H: 1.04%
C: -1.25%
electronics application device trial
Vymo has been recognized by Gartner® as a Representative Vendor in 2021 Gartner Market Guide for Sales Engagement Applications
Published: 2021-12-09 (Crawled : 13:30) - prnewswire.com
BNPQF | News | $70.45 -13.4% 1.8K
|
Finance
|
| O: -1.97%
H: 2.23%
C: 1.62%
BNPQY | News | $35.58 -2.68% 97K
|
Finance and Insurance
|
| O: -1.7%
H: 0.43%
C: -0.39%
gartner sales application
Bionano Genomics Announces 2022 Symposium Featuring Four Consecutive Days of OGM Presentations and Live Panel Discussions Delivered by 25 Different Customers Across a Wide Range of Genetic Disease and Cancer Applications
Published: 2021-12-09 (Crawled : 13:30) - globenewswire.com
BNGO | $0.7928 4.23% 4.06% 820K
|
Health Technology
|
| O: 1.65%
H: 1.36%
C: -4.61%
genetic application genomics genomic liver presentation disease genetic disease cancer symposium
Intercept Announces Withdrawal of EMA Marketing Authorization Application for Obeticholic Acid for Advanced Liver Fibrosis Due to NASH
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: -2.98%
H: 1.27%
C: -12.15%
ema fibrosis application liver authorization nash
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application to Initiate a Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
Published: 2021-12-09 (Crawled : 12:30) - globenewswire.com
OCGN | News A | $1.24 0.0% 6.9M
|
Health Technology
|
| O: 7.46%
H: 0.31%
C: -12.81%
ocu400 new drug fda application gene therapy drug trial fda acceptance phase 1 therapy retina
Night Vision Devices Market Size to Grow by USD 3.55 billion | Increased Applications in Military Operations to Drive Growth | Technavio
Published: 2021-12-09 (Crawled : 05:00) - prnewswire.com
ESLT | News | $203.79 0.85% 0.85% 11K
|
Electronic Technology
|
| O: 0.12%
H: 0.42%
C: -0.96%
application device growth
Applications Engineer – Intern
Published: 2021-12-09 (Crawled : 03:00) - aehr.com
AEHR F | $10.56 -0.28% -0.28% 630K
|
Electronic Technology
|
| O: 5.32%
H: 4.07%
C: -7.62%
application
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.